| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Endocrinology and Diabetes (J.P.W.), Sir Charles Gairdner Hospital, Perth, Western Australia 6009, Australia; Schools of Medicine and Pharmacology (J.P.W., P.J.L.), Population Health (A.P.B., M.K.B.), and Womens and Infants Health (P.O.), University of Western Australia, Western Australia 6009, Australia; Genomics Directorate (P.O.), Department of Health, Western Australia 6009, Australia; Laboratory for Cancer Medicine (P.J.L.), University of Western Australia Centre for Medical Research, Western Australian Institute for Medical Research, Perth, Western Australia 6000, Australia; Department of Endocrinology and Diabetes (P.J.L.), Royal Perth Hospital, Perth, Western Australia 6000, Australia; and Biomediq-DPC (P.F., V.M.), Doncaster, Victoria 3108, Australia
Address all correspondence and requests for reprints to: Dr. John P. Walsh, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia. E-mail: john.walsh{at}health.wa.gov.au.
Context: Recent studies have suggested that fetal microchimerism (transplacental passage of fetal cells followed by engraftment into maternal tissues) may play a role in the pathogenesis of autoimmune thyroid disease. If that is true, then parity should be a risk factor for autoimmune thyroid disease.
Objective: The objective of this study was to examine parity as a risk factor for autoimmune thyroid disease.
Design, Setting, and Participants: TSH, thyroid peroxidase antibody, and thyroglobulin antibody concentrations were measured on archived sera from 1045 female participants in a 1981 community health survey in Busselton, Western Australia.
Outcome Measures: Odds ratios (ORs) for positive thyroid antibodies (increased concentration of either antibody) or thyroid dysfunction (abnormal serum TSH) were used.
Results: After adjustment for age, women who had previously been pregnant did not have a significantly increased risk of positive thyroid antibodies [OR, 1.20; 95% confidence interval (CI), 0.741.97; P = 0.46], raised TSH (OR, 0.93; 95% CI, 0.461.87; P = 0.84), or reduced TSH (OR, 0.87; 95% CI, 0.332.30; P = 0.79) compared with women who had never been pregnant. For each additional pregnancy, the OR was 1.02 (95% CI, 0.941.11; P = 0.57) for positive antibodies, 1.02 (95% CI, 0.911.14; P = 0.67) for raised TSH, and 1.03 (95% CI, 0.871.22; P = 0.73) for reduced TSH. Analysis using number of live births gave similar results. The results were similar in younger and older women.
Conclusions: Parity is not a risk factor for thyroid autoimmunity or thyroid dysfunction. These data do not support a key pathogenic role for fetal microchimerism in chronic autoimmune thyroid disease.
This article has been cited by other articles:
![]() |
T. H. Brix, P. S. Hansen, K. O. Kyvik, and L. Hegedus Aggregation of Thyroid Autoantibodies in Twins from Opposite-Sex Pairs Suggests that Microchimerism May Play a Role in the Early Stages of Thyroid Autoimmunity J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4439 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Volzke, T. Ittermann, C. O Schmidt, M. Dorr, U. John, H. Wallaschofski, B. H C Stricker, S. B Felix, and R. Rettig Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study Eur. J. Endocrinol., October 1, 2009; 161(4): 615 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klintschar, U.-D. Immel, A. Kehlen, P. Schwaiger, T. Mustafa, S. Mannweiler, S. Regauer, M. Kleiber, and C. Hoang-Vu Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach Eur. J. Endocrinol., February 1, 2006; 154(2): 237 - 241. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |